Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GNG5 |
| Upstream (Parents) |
|---|
| (<<) CSNK1D → GNG5 |
| (<<) CSTB → GNG5 |
| (<<) EFHD2 → GNG5 |
| (<<) ELOVL1 → GNG5 |
| (<<) HRAS → GNG5 |
| (<<) KLHL7 → GNG5 |
| (<<) NBL1 → GNG5 |
| (<<) PPP1R11 → GNG5 |
| (<<) RHOG → GNG5 |
| (<<) RPS6KA1 → GNG5 |
| (<<) RRAS → GNG5 |
| (<<) S100P → GNG5 |
| (<<) SLC25A37 → GNG5 |
| Downstream (Children) |
|---|
| GNG5 → AKT1 (>>) |
| GNG5 → CASP9 (>>) |
| GNG5 → CREB3 (>>) |
| GNG5 → GYS1 (>>) |
| GNG5 → MKNK2 (>>) |
| GNG5 → NFATC4 (>>) |
| GNG5 → PIK3R2 (>>) |
| GNG5 → RPS6KA4 (>>) |
| GNG5 → SEPW1 (>>) |
| GNG5 → STAT2 (>>) |
| GNG5 → ZNF365 (>>) |
